Trian × General Electric — Nelson Peltz's $2B+ Loss and the 'Right Strategy, Wrong Timing' Activist Trade

By the mid-2010s the industrial conglomerate model was under structural pressure. The benefits of diversification (synergies, internal capital markets) had been overshadowed by the conglomerate discount, and a wave of breakups followed: ITT (2011), Tyco (2012), Alcoa (2016), and DowDuPont (2019). Activist funds — Trian, Third Point, Elliott — built campaigns around closing that discount. GE, founded by Edison in 1892 and the longest-standing symbol of American industrial capitalism, was the ultimate target. Jack Welch's GE Capital expansion (1981–2001) and the 2008 crisis had already exposed how fragile the conglomerate-with-a-bank model could be. Trian's arrival in 2015 came at the peak of this thematic shift.

Culp formally announced the three-way split on November 9, 2021, and completed it with the GE Vernova spin in April 2024. The select-and-focus strategy Trian set out in 2015 was ultimately executed in full. But Trian had already sold half its stake in August 2020 and captured only part of the recovery run that ran from sub-$10 in 2020 to GE Aerospace at over $300 by 2026. The strategic case was vindicated; the activist did not fully share in the vindication.

General Electric was formed in 1892 from the merger of Edison General Electric and Thomson-Houston, and for most of the twentieth century it was the embodiment of American industrial capitalism. Under Jack Welch (1981–2001) it briefly held the world's largest market capitalization at $594 billion (2000), built in large part on GE Capital's expansion. The 2008 crisis exposed how reliant GE Capital had become on short-term funding; Warren Buffett's Berkshire Hathaway provided $3 billion of emergency preferred stock. Under Immelt (2001–2017), GE began shrinking GE Capital and returning to its industrial roots, but capital allocation decisions — most notably the Alstom power acquisition in 2015 for $10.6 billion — left the power business badly exposed when the gas-turbine cycle turned. At the time of Trian's entry, GE was a sprawling combination of seven industrial segments (Power, Renewable Energy, Aviation, Healthcare, Transportation, Lighting, Digital) plus GE Capital.

Revenue by Segment (FY2014)

FY2014 revenue of $148.6B. GE Capital remained the single largest segment at 30 percent of revenue — precisely the segment Trian most wanted divested.

There is no conventional deal structure here. The trade is an activist position decomposed by timing, sizing, board access, and exit triggers. Trian deployed its own capital to buy common stock, initially on a 13G basis, then escalated via the white paper, cooperation agreement, and board seat — without ever filing a 13D or running a proxy contest. The cooperative architecture worked when there was one CEO to engage with; it diluted Trian's leverage as GE cycled through three CEOs in five years.

Trian conducted its analysis in-house — Peltz, Garden, and Matt Peltz authored the white paper — and used Edelman for strategic communications. GE retained different advisor lines for different phases. Centerview Partners and JPMorgan advised on the 2017–2018 dividend and restructuring decisions, with Davis Polk & Wardwell on the legal side. Morgan Stanley and PJT Partners joined for Culp's 2021 break-up.

Advisor information is drawn from public reporting and financial databases; some Trian-side legal engagements have not been formally confirmed.

Unit: $M. Consolidated including GE Capital. Revenue had been flat for five years going into the Trian campaign, with EBITDA around $26.8B in FY2014. Source: GE 10-K filings (2010–2014).

The valuation question here is not an acquisition price but the gap between Trian's white-paper price target and the actual stock trajectory. The October 2015 paper laid out a path to $40–45 per share by 2018, anchored on industrial EBITDA at a ~14× multiple, $20B of buybacks, and 18 percent industrial margins. Almost the opposite happened: Alstom impairments, two dividend cuts, the Dow removal, and the COVID aviation shock dragged the shares to roughly $6 by Trian's August 2020 sale — about -85 percent versus the white-paper target. The three-way split has since pushed combined value to roughly 2.8× GE's market cap at Trian's entry, suggesting the strategy was right but the holding period required was longer than the activist could carry.

Trian has not disclosed an exact cumulative loss figure and estimates differ across sources (a -$700M paper loss reported in 2018; a ~$400M realized loss on the August 2020 sale; residual marks depending on the recovery in GE Aerospace and the spin shares). This table reflects a synthesis of 13G filings, market data, and Bloomberg/Washington Post coverage.

Roughly ten years and eight months after Trian first disclosed its position, Larry Culp has executed the strategy Trian set out in 2015 almost exactly: GE HealthCare listed on Nasdaq in January 2023 (market cap ~$30B by June 2026), GE Vernova listed on NYSE in April 2024 (~$250B), and the surviving parent — renamed GE Aerospace — trades on NYSE with a market cap of roughly $345B. Combined, the three companies are worth about $625B, roughly 2.8 times GE's market capitalization when Trian entered. The white-paper case has been fully vindicated. Trian, however, sold 46 percent of its position in August 2020 at around $6 per share, crystallizing roughly $400M of losses on those shares. The residual stake (4.03M GE Aerospace shares at year-end 2024, plus the spin shares received in the breakup) has participated only partially in the recovery. Trian's largest-ever single position has become the textbook case of strategy right, timing wrong.